Abstract: An assembled half shell-shaped flanged bearing shell for a crankshaft bearing point in an internal combustion engine, having a half shell-shaped radial bearing part and having a disk-shaped axial bearing part that is fastenable in the area of an axial end-face side of the radial bearing part. The axial bearing part is formed from at least three segments that adjoin one another in the circumferential direction and that are nonreleasably joined together via a weld seam between every two segments, wherein the respective weld seam does not include the radial bearing part.

Abstract: An assembled half shell-shaped flanged bearing shell for a crankshaft bearing point in an internal combustion engine, having a half shell-shaped radial bearing part and having a disk-shaped axial bearing part that is fastenable in the area of an axial end-face side of the radial bearing part. The axial bearing part is formed from at least three segments that adjoin one another in the circumferential direction and that are nonreleasably joined together via a weld seam between every two segments, wherein the respective weld seam does not include the radial bearing part.

Abstract: The invention relates to a method for producing drug extracts that contain hydroxystilbene from a vegetable drug and to the use of various agents for pharmaceutical and non-pharmaceutical purposes.

Abstract: The invention provides novel hydroxystilbene-containing dosage forms, processes for producing these dosage forms and the use thereof for the treatment of menopausal symptoms in women, juvenile oligomenorrhea and dysmenorrhea, primary and secondary amenorrhea or endometritis.

Abstract: The invention relates to the use of a combination of active ingredients, selected from resveratrol and piceatannol precursors and functional derivatives thereof, in addition to the use of the stereoisomeric forms of said ingredients, in the form of salts or phenol respectively, for producing an agent for the prevention and/or treatment of diseases, whose occurrence and/or progress is associated with an increased IL-6 serum level and/or whose occurrence and/or progress can be treated by a dose of a selective oestrogen receptor .beta. (ER-?) agonist.

Abstract: The invention relates to the use of a combination of active ingredients, consisting essentially of rhaponticin and deoxyrhaponticin, their functional derivatives or the stereoisomeric forms thereof, in the form of salts or phenol respectively, for producing an agent for the prevention and/or treatment of diseases, whose occurrence and/or progress is associated with an increased IL-6 serum level and/or whose occurrence and/or progress can be treated by a dose of a selective oestrogen receptor ? (ER-?) agonist.

Abstract: The invention provides novel hydroxystilbene-containing dosage forms, processes for producing these dosage forms and the use thereof for the treatment of menopausal symptoms in women, juvenile oligomenorrhea and dysmenorrhea, primary and secondary amenorrhea or endometritis.

Abstract: The invention relates to novel dosage forms containing hydroxystilbene, to a method for producing said dosage forms and to their use for treating female menopausal complaints, juvenile oligomenorrhoea and dysmenorrhoea, primary and secondary amenorrhoea or endometritis.

Abstract: The invention relates to the use of a combination of active ingredients containing hydroxystilbene, selected from resveratrol and piceatannol precursors and functional derivatives thereof, in addition to the use of the stereoisomeric forms of said ingredients, in the form of salts or phenol respectively, for producing an agent for the prevention and/or treatment of osteoporosis.

Abstract: The invention relates to a method for producing drug extracts that contain hydroxystilbene from a vegetable drug and to the use of various agents for pharmaceutical and non-pharmaceutical purposes.

Abstract: The invention relates to the use of a combination of active ingredients, selected from resveratrol and piceatannol precursors and functional derivatives thereof, in addition to the use of the stereoisomeric forms of said ingredients, in the form of salts or phenol respectively, for producing an agent for the prevention and/or treatment of diseases, whose occurrence and/or progress is associated with an increased IL-6 serum level and/or whose occurrence and/or progress can be treated by a dose of a selective oestrogen receptor ? (ER-?) agonist.

Abstract: The invention relates to novel dosage forms containing hydroxystilbene, to a method for producing said dosage forms and to their use for treating female menopausal complaints, juvenile oligomenorrhoea and dysmenorrhoea, primary and secondary amenorrhoea or endometritis.